About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

A Better Path to Bladder Cancer Detection: The Role of Blue Light Cystoscopy

By: StatePoint Media

photo

SPONSORED CONTENT -- (StatePoint) When John noticed blood in his urine, he consulted his doctor and was quickly referred to a urologist. (John is a composite character, based on the experiences of real-life patients.)

John was diagnosed with bladder cancer using White Light Cystoscopy (WLC), a simple procedure for diagnosing non-muscle invasive bladder cancer (NMIBC). While this is the traditional diagnostic approach in most urology offices, it has limitations that can affect patient outcomes.

With WLC, it can be difficult to detect small lesions or flat lesions, such as carcinoma in situ (CIS). These missed tumors create the potential for cancer recurrence and the need for multiple transurethral resection of bladder tumors (TURBT) procedures. John, like many patients who receive WLC, had residual tumors after his initial TURBT and underwent multiple procedures to remove them.

John’s story is common and highlights the importance of accurate detection in early-stage bladder cancer. Fortunately, an enhanced procedure exists that significantly improves the visibility of bladder cancer lesions, especially hard-to-detect tumors like CIS. Blue Light Cystoscopy (BLC) uses an FDA-approved imaging agent—not a dye—that makes cancer cells glow bright pink under blue light. The BLC procedure uses both white and blue lights to help achieve the best possible detection results. When fewer tumors are missed, it reduces the need for repeat procedures, while also offering a more complete picture of the tumor situation. This information can lead to a more accurate diagnosis and inform more appropriate treatment moving forward.

Patients diagnosed with bladder cancer should be aware that BLC is not available in all hospitals and medical centers, so patients may need to do some research to find a urologist who offers this procedure. BLC also requires the administration of the imaging agent, which means patients must arrive at least one hour before the procedure to be prepped.

After John’s experiences with WLC, he reached out to a urologist who offers the BLC enhanced detection option. Using BLC, his urologist identified additional tumors, and the resulting more-precise diagnosis improved his follow-up care and required fewer surgeries down the line. As John learned, BLC at the outset could have limited his cycle of missed tumors and repeated surgeries.

According to medical experts, patients should not have to wait until their second or third TURBT to receive the BLC enhanced detection option. Better tumor detection has the potential to provide better data to drive more accurate diagnosis. The sooner a patient is properly diagnosed, the sooner the best possible treatment can be administered.

While WLC remains a valuable tool, incorporating BLC enhances the process and, as a result, can lead to improved detection that can drive improved outcomes for bladder cancer patients.

Given the many advantages of Blue Light Cystoscopy in detecting NMIBC tumors, patients should consider exploring this option and speaking with their urologist about it. To find a list of locations that offer BLC, visit: rebrand.ly/Locations-For-BLC.

This article is sponsored by Photocure, Inc.

*****

Photo Credit: (c) fizkes / Shutterstock.com

More News

View More
Why Affirm Could Be the Next Big Winner in Rate-Cut Rally
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers AFRM
Sprouts, Darden Offer High-Upside Setups for Risk-Takers
Via MarketBeat
Tickers DRI SFM
Jabils AI-Driven Boom Has Begun: News Highs are Coming
Via MarketBeat
Topics Artificial Intelligence
Tickers AAPL AMZN JBL JNJ
NuScale, Rocket Lab Face Heavy Insider Selling After Surges
Via MarketBeat
Tickers FLR RKLB SMR
CrowdStrike’s Investor Day Sparks Bullish Momentum
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers CRWD
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.